We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 83

SCOTUS sides with FTC in reverse payment deals
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

A divided U.S. Supreme Court has determined that patent-infringement settlement agreements requiring the patentee to pay the claimed infringer


U.S. Supreme Court issues ruling on patentability of human genes
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The U.S. Supreme Court has determined that while human genes and the information they encode are not patent eligible, despite the effort required to


Researchers conclude costs of litigation growing in relation to benefits of patent protections
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Economics, law and technology scholars affiliated with U.S. and German institutions have issued a paper that examines data on the costs of patent


En banc Federal Circuit issues ruling on appellate jurisdiction over patent infringement issues
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

The Federal Circuit Court of Appeals en banc has determined that parties may appeal the liability issues in a patent infringement action even if the


Court rules patent attorneys did not infringe scientific article copyrights
  • Shook Hardy & Bacon LLP
  • USA
  • June 6 2013

In a bench ruling, a federal court in Texas has reportedly determined that patent attorneys did not infringe scientific article copyrights by making


Federal Circuit applies Gunn, rules false statement about patent claim belongs in state court
  • Shook Hardy & Bacon LLP
  • USA
  • June 6 2013

The Federal Circuit Court of Appeals has determined that a dispute over allegedly false statements about patents did not raise a substantial question


Putative class alleges pharma statements about new drug violated securities laws
  • Shook Hardy & Bacon LLP
  • USA
  • May 16 2013

Aveo Pharmaceuticals, Inc. and several of its executives have been targeted in a securities class action filed in a federal court in Massachusetts


Federal Circuit issues seven opinions on patentability of software innovations
  • Shook Hardy & Bacon LLP
  • USA
  • May 16 2013

The en banc Federal Circuit Court of Appeals has divided over whether method and computer-readable media claims and system claims are directed to


SCOTUS unanimously rules GM soybean patent infringed
  • Shook Hardy & Bacon LLP
  • USA
  • May 16 2013

The U.S. Supreme Court has determined that the "exhaustion doctrine" does not apply in the context of a patented genetically modified (GM) seed, and


Life Tech shareholder sues to stop $13.6 billion sale to Thermo Fisher
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2013

According to a news source, Life Technologies shareholder Chang Choi has filed a lawsuit on behalf of a class of company shareholders alleging breach